|
Pfizer and Astellas Announce Top-Line Results from Phase 4 PLATO Trial of XTANDI® (enzalutamide)
|
4
|
Zenith Epigenetics
|
Dec 14, 2016 04:34PM
|
|
Re: 2019 Potential Events
|
4
|
Resverlogix Corp.
|
Jun 10, 2019 08:27PM
|
|
Re: BMO Current Value at 0
|
4
|
Zenith Epigenetics
|
Oct 31, 2018 02:15PM
|
|
Discount Brokerages - Zenith Valuations
|
3
|
Zenith Epigenetics
|
Jan 15, 2016 09:49AM
|
|
Re: THIS IS NEW !!!!
|
3
|
Resverlogix Corp.
|
Jan 15, 2016 09:52AM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 06:26PM
|
|
Re: Competition from Constellation
|
3
|
Zenith Epigenetics
|
Dec 14, 2017 11:15AM
|
|
Re: Zenith Updates
|
3
|
Zenith Epigenetics
|
Feb 02, 2016 07:02PM
|
|
Zenith Revalued at Investorline
|
3
|
Zenith Epigenetics
|
Aug 09, 2019 09:42AM
|
|
Presentation at BIO 2016
|
3
|
Resverlogix Corp.
|
Jun 07, 2016 02:37PM
|
|
Re: AMRN Adcom
|
3
|
Resverlogix Corp.
|
Aug 09, 2019 01:40PM
|
|
Re: European Atherosclerosis Society 2019 meeting May 26-29
|
3
|
Resverlogix Corp.
|
May 20, 2019 12:56PM
|
|
Re: Contest Tally
|
3
|
Resverlogix Corp.
|
Feb 12, 2019 02:03PM
|
|
Re: Buyers need sellers....why I think delivery failures are important
|
3
|
Resverlogix Corp.
|
Nov 09, 2019 01:36PM
|
|
Re: TSX Buy -Ins...
|
3
|
Resverlogix Corp.
|
Jun 19, 2018 07:21PM
|
|
Re: Diving into....
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 10:21AM
|
|
Some additional COVID 19 gene targets
|
3
|
Resverlogix Corp.
|
Dec 11, 2020 06:15PM
|
|
Re: BIO CEO Slides Up
|
3
|
Zenith Epigenetics
|
Feb 14, 2019 09:17AM
|
|
Analyst Rating Change Notice
|
3
|
Resverlogix Corp.
|
Jan 09, 2017 08:45AM
|
|
Re: Generic Crestor
|
3
|
Resverlogix Corp.
|
Jul 20, 2016 07:31PM
|
